PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
UTHR vs. BBH
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between UTHR and BBH is 0.47, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.5

Performance

UTHR vs. BBH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in United Therapeutics Corporation (UTHR) and VanEck Vectors Biotech ETF (BBH). The values are adjusted to include any dividend payments, if applicable.

1,200.00%1,400.00%1,600.00%1,800.00%2,000.00%2,200.00%JulyAugustSeptemberOctoberNovemberDecember
1,856.90%
1,157.38%
UTHR
BBH

Key characteristics

Sharpe Ratio

UTHR:

2.10

BBH:

0.00

Sortino Ratio

UTHR:

2.79

BBH:

0.12

Omega Ratio

UTHR:

1.39

BBH:

1.01

Calmar Ratio

UTHR:

2.39

BBH:

0.00

Martin Ratio

UTHR:

12.14

BBH:

0.01

Ulcer Index

UTHR:

4.90%

BBH:

5.03%

Daily Std Dev

UTHR:

28.35%

BBH:

16.56%

Max Drawdown

UTHR:

-93.18%

BBH:

-72.69%

Current Drawdown

UTHR:

-12.30%

BBH:

-27.38%

Returns By Period

In the year-to-date period, UTHR achieves a 63.53% return, which is significantly higher than BBH's -4.08% return. Over the past 10 years, UTHR has outperformed BBH with an annualized return of 10.72%, while BBH has yielded a comparatively lower 3.89% annualized return.


UTHR

YTD

63.53%

1M

-2.12%

6M

13.78%

1Y

64.24%

5Y*

31.74%

10Y*

10.72%

BBH

YTD

-4.08%

1M

-1.13%

6M

-5.76%

1Y

-1.55%

5Y*

2.50%

10Y*

3.89%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

UTHR vs. BBH - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for United Therapeutics Corporation (UTHR) and VanEck Vectors Biotech ETF (BBH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for UTHR, currently valued at 2.10, compared to the broader market-4.00-2.000.002.002.100.00
The chart of Sortino ratio for UTHR, currently valued at 2.79, compared to the broader market-4.00-2.000.002.004.002.790.12
The chart of Omega ratio for UTHR, currently valued at 1.39, compared to the broader market0.501.001.502.001.391.01
The chart of Calmar ratio for UTHR, currently valued at 2.39, compared to the broader market0.002.004.006.002.390.00
The chart of Martin ratio for UTHR, currently valued at 12.14, compared to the broader market-5.000.005.0010.0015.0020.0025.0012.140.01
UTHR
BBH

The current UTHR Sharpe Ratio is 2.10, which is higher than the BBH Sharpe Ratio of 0.00. The chart below compares the historical Sharpe Ratios of UTHR and BBH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.002.503.00JulyAugustSeptemberOctoberNovemberDecember
2.10
0.00
UTHR
BBH

Dividends

UTHR vs. BBH - Dividend Comparison

Neither UTHR nor BBH has paid dividends to shareholders.


TTM20232022202120202019201820172016201520142013
UTHR
United Therapeutics Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
BBH
VanEck Vectors Biotech ETF
0.00%0.43%0.47%0.21%0.36%0.34%0.50%0.55%0.30%0.27%0.00%0.00%

Drawdowns

UTHR vs. BBH - Drawdown Comparison

The maximum UTHR drawdown since its inception was -93.18%, which is greater than BBH's maximum drawdown of -72.69%. Use the drawdown chart below to compare losses from any high point for UTHR and BBH. For additional features, visit the drawdowns tool.


-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-12.30%
-27.38%
UTHR
BBH

Volatility

UTHR vs. BBH - Volatility Comparison

United Therapeutics Corporation (UTHR) has a higher volatility of 8.49% compared to VanEck Vectors Biotech ETF (BBH) at 5.16%. This indicates that UTHR's price experiences larger fluctuations and is considered to be riskier than BBH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%14.00%JulyAugustSeptemberOctoberNovemberDecember
8.49%
5.16%
UTHR
BBH
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab